DL-Norvaline (CAS 760-78-1): Enhancing Peptide Synthesis with Non-Proteinogenic Amino Acids
In the realm of peptide synthesis, the incorporation of non-proteinogenic amino acids has become a powerful strategy for modulating the properties and functionalities of therapeutic peptides. DL-Norvaline, identified by CAS 760-78-1, is one such amino acid that offers unique advantages when used as a building block. For researchers and peptide synthesis specialists looking to buy DL-Norvaline, understanding its applications and sourcing from reliable manufacturers is key to success.
DL-Norvaline is an isomer of the proteinogenic amino acid L-norvaline. Its inclusion in a peptide sequence can impart enhanced resistance to enzymatic degradation, thereby increasing the peptide's half-life in biological systems. This stability is critical for developing peptides with improved pharmacokinetic profiles, making them more effective as drug candidates. Furthermore, the structural differences introduced by DL-Norvaline can influence the peptide's conformation and receptor binding affinity, potentially leading to optimized biological activity.
When embarking on peptide synthesis projects, sourcing high-purity DL-Norvaline is essential. Manufacturers who adhere to strict quality control standards, ensuring an assay of 98.5% or higher, are preferred. Researchers often seek out suppliers in China known for their expertise in fine chemical production, as these can offer competitive pricing and reliable availability of specialized amino acids like DL-Norvaline. The ability to procure this compound from a trusted manufacturer ensures that the synthetic peptides will meet the rigorous purity requirements for preclinical and clinical research.
The process of incorporating DL-Norvaline into a peptide chain typically involves standard peptide coupling chemistries, similar to those used for proteinogenic amino acids. However, the racemic nature of DL-Norvaline means that careful consideration of stereochemistry might be necessary depending on the specific application. Peptide synthesis companies and academic research labs looking to buy DL-Norvaline should prioritize suppliers who provide clear technical data and support. By strategically sourcing DL-Norvaline, researchers can unlock new possibilities in peptide design, leading to the development of novel and more potent therapeutic agents.
Perspectives & Insights
Nano Explorer 01
“When embarking on peptide synthesis projects, sourcing high-purity DL-Norvaline is essential.”
Data Catalyst One
“Manufacturers who adhere to strict quality control standards, ensuring an assay of 98.”
Chem Thinker Labs
“Researchers often seek out suppliers in China known for their expertise in fine chemical production, as these can offer competitive pricing and reliable availability of specialized amino acids like DL-Norvaline.”